Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic architecture of prostate cancer in the Ashkenazi Jewish population.

British journal of cancer - 6 Sept 2011

Vijai J, Kirchhoff T, Gallagher D, Hamel N, Guha S, Darvasi A, Lencz T, Foulkes W D, Offit K, Klein R J

Abstract excerpt

BACKGROUND: Recently, numerous prostate cancer risk loci have been identified, some of which show association in specific populations. No study has yet investigated whether these single nucleotide polymorphisms (SNPs) are associated with prostate cancer in the Ashkenazi Jewish (AJ) population. METHODS: A total of 29 known prostate cancer risk SNPs were genotyped in 963 prostate cancer cases and 613 controls of AJ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Genotype

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 21829199
DOI: 10.1038/bjc.2011.307
PMCID: PMC3171013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic architecture of prostate cancer in the Ashkenazi Jewish population.PMID 21829199Read ↗

Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry.Semantic proximity Read ↗

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.Semantic proximity Read ↗

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.Semantic proximity Read ↗

Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.Semantic proximity Read ↗

BRCA mutations and risk of prostate cancer in Ashkenazi Jews.Semantic proximity Read ↗

Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancerSemantic proximity Read ↗

Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer.Semantic proximity Read ↗

A twofold increase in <i>BRCA</i> mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathologySemantic proximity Read ↗

RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients.Semantic proximity Read ↗

High mammographic density in women of Ashkenazi Jewish descent.Semantic proximity Read ↗

A genome-wide genetic signature of Jewish ancestry perfectly separates individuals with and without full Jewish ancestry in a large random sample of European Americans.Semantic proximity Read ↗

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.